12 September 2024:

TROG Cancer Research has outlined how it plans to further the organisation’s vital work advancing and diversifying radiation medicine research over the next three years.

The TROG Cancer Research Strategic Plan 2024-2026 outlines our strategic priorities, key initiatives that will be undertaken over the three-year-period, and key performance indicators to measure success in achieving these priorities.

In line with TROG’s vision, mission and values, the Strategic Plan centres on four strategic goals, each of which encompass several key objectives:

1. Diversifying our research and enhancing access: We will increase both the quantity and diversity of our radiation medicine research initiatives.
2. Developing collaborative networks: We will establish strong, mutually beneficial partnerships with national and international academic institutions, professional organisations, healthcare facilities and industry partner.
3. Fostering member engagement and stakeholder communication: We recognise the importance of building strong relationships with all stakeholder and our goals focus on developing comprehensive communications plans, engaging with different stakeholder groups, organising events and working with our members.
4. Enhancing funding, infrastructure, and sustainability: The longevity and impact of our research depends on secure funding and the ability modernise infrastructure.

“Our forward agenda is strategically aligned with the Australian Cancer Plan 2023-2033 (ACP), aiming to strengthen TROG’s ability to advance the ACP’s objectives,” TROG Cancer Research CEO Susan Goode said. “We are committed to improving care and treatment outcomes for those affected by cancer, while continuing to foster a bi-national approach in our research across Australia and New Zealand.”

Read more about the TROG Cancer Research Strategic Plan 2024-2026.